Alaska Air Group, Inc. (ALK)

Revance Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,225	8,220	5,003	5,446	6,529	6,431
Market Cap Growth	17.17%	64.29%	-8.14%	-16.58%	1.53%	-22.94%
Enterprise Value	10,474	11,857	6,679	6,251	7,450	8,097
Last Close Price	54.00	64.75	39.07	42.94	52.10	52.00
PE Ratio	21.72	20.81	21.29	93.90	13.66	-
Forward PE	12.70	11.99	9.88	8.85	14.82	-
PS Ratio	0.50	0.70	0.48	0.56	1.06	1.80
PB Ratio	1.58	1.88	1.22	1.43	1.72	2.15
P/TBV Ratio	16.64	10.61	2.40	3.06	3.72	6.86
P/FCF Ratio	-	44.92	-	-	8.85	-
P/OCF Ratio	4.36	5.62	4.76	3.84	6.34	-
EV/Sales Ratio	0.78	1.01	0.64	0.65	1.21	2.27
EV/EBITDA Ratio	7.13	8.32	5.37	5.66	54.38	-
EV/EBIT Ratio	13.19	13.34	8.16	8.86	-	-
EV/FCF Ratio	-	64.79	-	-	10.09	-
Debt / Equity Ratio	1.62	1.46	0.93	0.99	1.08	1.70
Debt / EBITDA Ratio	2.59	2.91	1.97	2.09	5.18	-
Debt / FCF Ratio	-	34.93	-	-	5.55	-
Asset Turnover	0.76	0.68	0.72	0.69	0.44	0.26
Inventory Turnover	64.08	56.34	72.39	90.52	90.07	67.43
Quick Ratio	0.43	0.49	0.49	0.61	0.92	0.89
Current Ratio	0.52	0.61	0.61	0.68	0.98	0.93
Return on Equity (ROE)	7.66%	9.31%	5.93%	1.52%	14.08%	-36.18%
Return on Assets (ROA)	2.82%	3.23%	3.55%	3.14%	-1.15%	-10.81%
Return on Capital (ROIC)	5.39%	5.94%	6.59%	5.70%	-2.01%	-18.72%
Return on Capital Employed (ROCE)	6.00%	6.50%	8.10%	7.30%	-	-
Earnings Yield	5.03%	4.81%	4.70%	1.06%	7.32%	-20.59%
FCF Yield	-0.13%	2.23%	-8.88%	-4.64%	11.30%	-7.09%
Dividend Yield	-	-	-	-	-	0.72%
Buyback Yield / Dilution	1.69%	0.26%	-0.63%	-0.89%	-2.69%	0.68%
Total Shareholder Return	1.69%	0.26%	-0.63%	-0.89%	-2.69%	1.40%

Updated Jul 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q